Bhinneka News Online: Reuters Health Report: December 6, 2017

Wednesday, 6 December 2017

Reuters Health Report: December 6, 2017

Click to View in Browser

Wednesday, December 6, 2017

FDA approves Novo Nordisk diabetes drug Ozempic

(Reuters) - The U.S. Food and Drug Administration on Tuesday approved Novo Nordisk A/S's diabetes drug Ozempic, setting the stage for a heated battle with Eli Lilly & Co's Trulicity.

GSK, other drugmakers bet on post-Brexit UK science

LONDON (Reuters) - Britain won a vote of confidence from its economically important life sciences sector on Wednesday as five drug companies committed to invest in the country under the government's industrial strategy plans after Brexit.

Philippines halts sale of dengue vaccine as Sanofi downplays risk

MANILA/LONDON (Reuters) - The Philippines has ordered French drugmaker Sanofi to stop the sale, distribution and marketing of its Dengvaxia dengue vaccine in the country after the company last week warned it could worsen the disease in some cases.

Paraguay Congress legalizes planting of medical marijuana

ASUNCION (Reuters) - Paraguay's Congress passed a bill on Tuesday creating a state-sponsored system to import marijuana seeds and grow the plant for medical uses, a decision that followed other countries in Latin America.

Australian watchdog takes GlaxoSmithKline, Novartis units to court

(Reuters) - The Australian Competition and Consumer Commission (ACCC) on Wednesday said it is taking local units of GlaxoSmithKline and Swiss healthcare company Novartis to court over false or misleading representations in the marketing of pain relief products.

Consistently lower cancer survival rates for black patients in U.S.

(Reuters Health) - Whether it's colon cancer, breast cancer, or ovarian cancer, survival rates in the U.S. are lower for black people than for white people, three new studies show.

Brazil, U.S. identify molecule to help fight citrus greening disease

SAO PAULO (Reuters) - Researchers have identified the molecule that attracts the insect that transmits citrus greening disease, a development expected to help farmers control a plague that has destroyed trees in growing regions of Brazil and the United States.

Women get mixed messages about sexuality after childbirth

(Reuters Health) - Women receive mixed messages about the ways giving birth may affect their sex lives, according to a new report.

Nestle to buy vitamin maker Atrium Innovations for $2.3 billion

LONDON (Reuters) - Nestle is buying Canadian vitamin maker Atrium Innovations for $2.3 billion, expanding its presence in consumer healthcare as it seeks to offset weakness in packaged foods.

Jury orders Bayer, J&J to pay $28 million in Xarelto lawsuit

(Reuters) - A Philadelphia state court jury on Tuesday ordered Bayer AG and Johnson & Johnson to pay $27.8 million to an Indiana couple over the drugmakers' failure to warn of internal bleeding risks from their blood thinner Xarelto.